Asan Medical Center

Seoul, Gyeonggido 138-736

0 studies enrolling now · 3 studies all time

What they study most

Adenoid Cystic Carcinoma, Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult, Liver Cell Carcinoma, Adult, T-cell Lymphoma

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) — Stopped early
• A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma — Running, not enrolling
• Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma — Completed